• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,737.43 289.30
(0.61%)
Dow Jones
6,869.48 35.87
(0.52%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,721.02 27.09
(0.28%)
Forex
USD-INR
89.30 0.10
(0.11%)
EUR-INR
103.54 0.22
(0.21%)
GBP-INR
118.23 0.49
(0.41%)
JPY-INR
0.57 0.00
(0.17%)

EQUITY - MARKET SCREENER

Zim Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541400
INE518E01015
49.9263671
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZIMLAB
43.27
354.26
EPS(TTM)
Face Value()
Div & Yield %
1.68
10
0
 

B. L. Kashyap advances after securing order worth Rs 254 crore from DLF Home Developers
Nov 25,2025

The contract is for the execution of civil structural, rough finishing, and waterproofing work at Sector 63 in Gurugram. The project scope specifically covers one high-rise tower, associated low-rise buildings, and ancillary structures.

The company is required to complete the project within a period of 37 months.

B. L. Kashyap and Sons is an EPC company engaged in the business of construction of high-rise residential and commercial complexes, IT parks, institutional buildings, etc.